Equities research analysts at Deutsche Bank initiated coverage on shares of Nextgen Healthcare (NASDAQ:NXGN) in a research report issued to clients and investors on Thursday, The Fly reports. The firm set a “hold” rating and a $15.00 price target on the stock. Deutsche Bank’s price objective would suggest a potential downside of 6.48% from the […]
